Ingevity Corp (NYSE:NGVT) – Analysts at Jefferies Group issued their FY2018 EPS estimates for Ingevity in a research note issued to investors on Thursday. Jefferies Group analyst D. Rizzo anticipates that the company will post earnings per share of $3.45 for the year. Jefferies Group currently has a “Buy” rating and a $92.00 price target on the stock. Jefferies Group also issued estimates for Ingevity’s FY2019 earnings at $4.65 EPS and FY2020 earnings at $6.50 EPS.
NGVT has been the topic of a number of other reports. SunTrust Banks reiterated a “buy” rating and set a $90.00 price objective on shares of Ingevity in a research note on Friday, February 23rd. Zacks Investment Research upgraded shares of Ingevity from a “hold” rating to a “strong-buy” rating and set a $89.00 price objective on the stock in a research note on Saturday, February 24th. Loop Capital downgraded shares of Ingevity from a “buy” rating to a “hold” rating and set a $80.00 price objective on the stock. in a research note on Tuesday, February 27th. KeyCorp reiterated an “overweight” rating and set a $89.00 price objective (up from $78.00) on shares of Ingevity in a research note on Friday, February 23rd. Finally, Rowe reiterated an “outperform” rating and set a $90.00 price objective (up from $80.00) on shares of Ingevity in a research note on Thursday, November 30th. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $86.13.
Ingevity (NYSE:NGVT) last issued its earnings results on Tuesday, February 20th. The company reported $0.45 EPS for the quarter, topping the Zacks’ consensus estimate of $0.36 by $0.09. The business had revenue of $229.50 million for the quarter, compared to the consensus estimate of $214.94 million. Ingevity had a net margin of 12.99% and a return on equity of 50.74%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.34 EPS.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Xact Kapitalforvaltning AB bought a new position in shares of Ingevity during the fourth quarter valued at approximately $263,000. Segall Bryant & Hamill LLC boosted its stake in shares of Ingevity by 10.3% during the fourth quarter. Segall Bryant & Hamill LLC now owns 85,802 shares of the company’s stock valued at $6,046,000 after purchasing an additional 8,017 shares in the last quarter. MetLife Investment Advisors LLC purchased a new stake in Ingevity during the fourth quarter valued at approximately $1,313,000. Gotham Asset Management LLC lifted its stake in shares of Ingevity by 527.8% in the fourth quarter. Gotham Asset Management LLC now owns 23,518 shares of the company’s stock worth $1,657,000 after buying an additional 19,772 shares in the last quarter. Finally, Jane Street Group LLC purchased a new position in shares of Ingevity in the fourth quarter worth about $206,000. Hedge funds and other institutional investors own 89.94% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://sportsperspectives.com/2018/03/14/ingevity-corp-expected-to-post-fy2018-earnings-of-3-45-per-share-ngvt.html.
Ingevity Company Profile
Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.